Ignite Creation Date:
2024-05-05 @ 10:00 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00002504
Status:
COMPLETED
Last Update Posted:
2011-05-12
First Post:
1999-11-01
Brief Title:
Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer
Sponsor:
Hoag Memorial Hospital Presbyterian
Organization:
Hoag Memorial Hospital Presbyterian
Study Overview
Official Title:
OUTPATIENT SUBCUTANEOUS IL-2 AND ALPHA INTERFERON IN THE MANAGEMENT OF METASTATIC CANCER
Status:
COMPLETED
Status Verified Date:
2011-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
RATIONALE Interleukin-2 may stimulate a persons white blood cells to kill metastatic cancer cells Interferon alfa may interfere with the growth of the cancer cells Combining interleukin-2 and interferon alfa may kill more cancer cells
PURPOSE Phase II trial to study the effectiveness of interleukin-2 plus interferon alfa in treating adults with metastatic cancer
PURPOSE Phase II trial to study the effectiveness of interleukin-2 plus interferon alfa in treating adults with metastatic cancer
Detailed Description:
OBJECTIVES I Determine the response rate failure-free survival and overall survival of interleukin-2 and interferon alpha administered subcutaneously on an outpatient basis for 8 weeks to patients with metastatic cancer II Determine the toxicities associated with this therapy
OUTLINE Biological Response Modifier Therapy Interleukin-2 Cetus IL-2 NSC-373364 Interferon alpha Schering IFN-A NSC-377523
PROJECTED ACCRUAL Up to 30 patients with various malignancies will be entered
OUTLINE Biological Response Modifier Therapy Interleukin-2 Cetus IL-2 NSC-373364 Interferon alpha Schering IFN-A NSC-377523
PROJECTED ACCRUAL Up to 30 patients with various malignancies will be entered
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-V92-0148 | None | None | None |
| CBRG-9211 | None | None | None |
| NBSG-9211 | None | None | None |